INVO Fertility, Inc. (IVF) - Total Liabilities
Based on the latest financial reports, INVO Fertility, Inc. (IVF) has total liabilities worth $12.98 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of INVO Fertility, Inc. to see how much of total assets are deployed in long-term investments.
INVO Fertility, Inc. - Total Liabilities Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see INVO Fertility, Inc. asset portfolio.
INVO Fertility, Inc. Competitors by Total Liabilities
The table below lists competitors of INVO Fertility, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BELGRAVIA HARTFORD CAP.
F:ECA
|
Germany | €2.63 Million |
|
Mantex AB
ST:MANTEX
|
Sweden | Skr16.40 Million |
|
INCUVO S.A. ZY -50
F:68X
|
Germany | €2.42 Million |
|
Akanda Corp
NASDAQ:AKAN
|
USA | $18.19 Million |
|
Bohra Industries Limited
NSE:BOHRAIND
|
India | Rs62.65 Million |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
Finland | €5.58 Million |
|
WILDCAT PRETR.LS -000028
F:8Y6
|
Germany | €54.00K |
|
Heritage Distilling Holding Company, Inc.
NASDAQ:IPST
|
USA | $10.36 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down INVO Fertility, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IVF net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INVO Fertility, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INVO Fertility, Inc. (2006–2024)
The table below shows the annual total liabilities of INVO Fertility, Inc. from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $33.70 Million | +91.34% |
| 2023-12-31 | $17.61 Million | +275.76% |
| 2022-12-31 | $4.69 Million | +48.54% |
| 2021-12-31 | $3.16 Million | -39.36% |
| 2020-12-31 | $5.20 Million | -5.53% |
| 2019-12-31 | $5.51 Million | +57.33% |
| 2018-12-31 | $3.50 Million | -33.41% |
| 2017-12-31 | $5.26 Million | +7.23% |
| 2016-12-31 | $4.90 Million | +13.08% |
| 2015-12-31 | $4.34 Million | -2.92% |
| 2014-12-31 | $4.47 Million | +13.45% |
| 2013-12-31 | $3.94 Million | +12.56% |
| 2012-12-31 | $3.50 Million | +14.57% |
| 2011-12-31 | $3.05 Million | +14.65% |
| 2010-12-31 | $2.66 Million | -24.46% |
| 2009-12-31 | $3.52 Million | +256.73% |
| 2008-12-31 | $988.12K | +530.59% |
| 2007-12-31 | $156.70K | +62579.20% |
| 2006-12-31 | $250.00 | -- |
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more